(Y46.7) Antiparkinsonism drugs

More details coming soon

Icon
24 262 in individuals diagnosis antiparkinsonism drugs confirmed
Icon
2 651 deaths with diagnosis antiparkinsonism drugs
Icon
11% mortality rate associated with the disease antiparkinsonism drugs

Diagnosis antiparkinsonism drugs is diagnosed Women are 27.64% more likely than Men

8 778

Men receive the diagnosis antiparkinsonism drugs

0 (less than 0.1%)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
15 484

Women receive the diagnosis antiparkinsonism drugs

2 651 (17.1 %)

Died from this diagnosis.

Risk Group for the Disease antiparkinsonism drugs - Men aged 25-29 and Women aged 60-64

Icon
In Men diagnosis is most often set at age 0-5, 25-39, 50-59, 70-74
Icon
Less common in men the disease occurs at Age 0-1, 5-24, 40-49, 60-69, 75-95+Less common in women the disease occurs at Age 0-1, 5-34, 45-49, 85-95+
Icon
In Women diagnosis is most often set at age 0-5, 35-44, 50-84

Disease Features antiparkinsonism drugs

Icon
Absence or low individual and public risk
Icon

Antiparkinsonism drugs - what does this mean

Antiparkinsonism drugs are drugs used to treat parkinson's disease, a neurodegenerative disorder that affects movement and is caused by the death of dopamine-producing neurons in the brain. these drugs work by increasing the amount of dopamine in the brain, helping to restore normal movement and control of body movements.

What happens during the disease - antiparkinsonism drugs

Antiparkinsonism drugs work by blocking the action of dopamine in the brain, which is the primary neurotransmitter responsible for the movement of muscles. when dopamine is blocked, the amount of dopamine available to the brain is reduced, allowing for more normal movement of muscles and reducing the symptoms of parkinson's disease.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Physical Exam
  • Neurological Exam
  • Blood Tests
  • Urine Tests
  • Imaging Tests (e.g. MRI, CT scan)
  • Electroencephalogram (EEG)
  • Drug Challenge Test
  • Genetic Testing

Treatment and Medical Assistance

Main goal: To reduce the symptoms of antiparkinsonism drugs
  • Prescribe medications to reduce symptoms
  • Regularly monitor patient's response to medications
  • Provide lifestyle advice to the patient
  • Encourage the patient to take part in physical activities
  • Provide psychological support to the patient
  • Educate the patient and his family about the disease
  • Refer the patient to a specialist if needed
Icon
13 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Antiparkinsonism drugs - Prevention

Antiparkinsonism drugs can help to prevent the symptoms of parkinson's disease by blocking the breakdown of dopamine, a neurotransmitter that helps control movement. they can also increase the amount of dopamine available in the brain, allowing patients to move more freely and with less difficulty. additionally, lifestyle changes such as regular exercise, a balanced diet, and stress management can help to reduce the risk of developing parkinson's disease.